Resistance 101 1.1

In the realm of combating malaria, addressing insecticide resistance emerges as a pivotal aspect. Resistance 101 presents itself as an immersive, arcade-style game that serves as an educational tool on insecticide resistance and its significance in the battle against malaria. Through this platform, players can delve into various resistance mechanisms, gaining insights into their manifestations and the management of mosquito populations via the application of insecticides.

Embark on the challenge presented by Resistance 101, offering 26 levels of interactive gameplay requiring nimble finger tapping skills. Supplementing gameplay are 8 informative videos that elucidate the core principles of insecticide resistance. Test your capabilities, overcome obstacles, and strive to achieve a coveted 3-star rating on each level—all without encountering disruptions from advertisements or in-app purchases.

• Engage with masterful mosquito control mechanisms across 26 diverse levels.
• Access 8 visually stunning videos elucidating the fundamentals of insecticide resistance.
• Challenge yourself to attain 3 stars on every level, showcasing your proficiency.
• Enjoy an ad-free experience, free from any in-app purchases.

If you find Resistance 101 enthralling and edifying, we welcome you to share your feedback through a review. Further details regarding Resistance 101 can be found on our website at www.etch.lstmed.ac.uk. For inquiries or if you wish to explore the use of Resistance 101 as an educational tool, kindly reach out to us via email at [email protected].

Resistance 101 forms a part of the comprehensive ResistanceSim tool package designed to address challenges in managing insecticide resistance. ResistanceSim provides players with a simulation platform to control pivotal elements of vector control. To discover more about ResistanceSim or to engage with us, please visit our website and get in touch.

Produced by the Liverpool School of Tropical Medicine and Extra Mile Studios, Resistance 101 has received funding from the European Union through the DMC-MalVec Consortium and backing from the Bill & Melinda Gates Foundation via IVCC.